Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorDi Cosimo, Serena
dc.contributor.authorPorcu, Luca
dc.contributor.authorMalfettone, Andrea
dc.contributor.authorCortés Castan, Javier
dc.contributor.authorMiceli, Rosalba
dc.date.accessioned2021-09-10T10:06:39Z
dc.date.available2021-09-10T10:06:39Z
dc.date.issued2020-07-10
dc.identifier.citationDi Cosimo S, Porcu L, Malfettone A, Cortés J, Miceli R. Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. Front Oncol. 2020 Jul 10;10:1223.
dc.identifier.issn2234-943X
dc.identifier.urihttp://hdl.handle.net/11351/6298
dc.descriptionCOVID-19; Cancer care; Patient guidance
dc.description.abstractA Commentary on: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. By Yu, J., Ouyang, W., Chua, M. L. K., and Xie, C. (2020). JAMA Oncol. doi: 10.1001/jamaoncol.2020.0980:ca_ES
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Oncology;10
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCàncer - Xina
dc.subjectCOVID-19 (Malaltia) - Xina
dc.subject.meshCoronavirus Infections
dc.subject.meshNeoplasms
dc.subject.meshChina
dc.titleCommentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fonc.2020.01223
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsneoplasias
dc.subject.decsChina
dc.relation.publishversionhttps://doi.org/10.3389/fonc.2020.01223
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Di Cosimo S] Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. [Porcu L] Laboratory of Methodology for Clinical Research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. [Malfettone A] Medica Scientia Innovation Research (MedSIR), New Jersey, United States. [Cortés J] Medica Scientia Innovation Research (MedSIR), New Jersey, United States. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. IOB Institute of Oncology, Quiron Group, Madrid, Spain. IOB Institute of Oncology, Quiron Group, Barcelona, Spain. Vall d'Hebron Insititute of Oncology (VHIO), Barcelona, Spain. [Miceli R] Clinical Epidemiology and Trial Organization Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
dc.identifier.pmid32754446
dc.identifier.wos000555929000001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record